Dependent Archives - World Asthma Foundation

August 22, 2015

Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma

Condition: Asthma
Interventions: Drug: Dupilumab SAR231893 (REGN668); Drug: Placebo; Drug: asthma controller therapies (including prednisone/prednisolone)
Sponsors: Sanofi; Regeneron Pharmaceuticals
Not yet recruiting – verified August 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

July 20, 2015

An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils

Conditions: Asthma; Elevated Blood Eosinophils
Interventions: Drug: Reslizumab; Drug: Placebo
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified July 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

November 7, 2014

A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Oral Corticosteroid Dependent Asthma (TROPOS)

Condition: Oral Corticosteroid Dependent Asthma
Interventions: Biological: Tralokinumab; Other: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified October 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days